{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T22:40:41Z","timestamp":1688078441975},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T00:00:00Z","timestamp":1362528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00108-012-3186-3","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T01:52:28Z","timestamp":1362448348000},"page":"408-415","source":"Crossref","is-referenced-by-count":1,"title":["Interleukin-1-vermittelte Erkrankungen","Interleukin-1-mediated diseases"],"prefix":"10.1007","volume":"54","author":[{"given":"D.","family":"Holzinger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Jacobi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,6]]},"reference":[{"key":"3186_CR1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2009.05.005","volume":"30","author":"Brydges","year":"2009","unstructured":"Brydges SD, Mueller JL, McGeough MD et\u00a0al (2009) Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity 30:875\u2013887","journal-title":"Immunity"},{"key":"3186_CR2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ni.2231","volume":"13","author":"Franchi","year":"2012","unstructured":"Franchi L, Munoz-Planillo R, Nunez G (2012) Sensing and reacting to microbes through the inflammasomes. Nat Immunol 13:325\u2013332","journal-title":"Nat Immunol"},{"key":"3186_CR3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","volume":"27","author":"Masters","year":"2009","unstructured":"Masters SL, Simon A, Aksentijevich I, Kastner\u00a0DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). Annu Rev Immunol 27:621\u2013668","journal-title":"Annu Rev Immunol"},{"key":"3186_CR4","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1002\/art.23474","volume":"58","author":"Gattorno","year":"2008","unstructured":"Gattorno M, Sormani MP, D\u2019Osualdo A et\u00a0al (2008) A diagnostic score for molecular analysis of hereditary autoinflammatory syndromes with periodic fever in children. Arthritis Rheum 58:1823\u20131832","journal-title":"Arthritis Rheum"},{"key":"3186_CR5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0140-6736(97)09408-7","volume":"351","author":"Ben-Chetrit","year":"1998","unstructured":"Ben-Chetrit E, Levy M (1998) Familial Mediterranean fever. Lancet 351:659\u2013664","journal-title":"Lancet"},{"key":"3186_CR6","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s00431-012-1803-8","volume":"171","author":"Lainka","year":"2012","unstructured":"Lainka E, Bielak M, Lohse P et\u00a0al (2012) Familial Mediterranean fever in Germany: epidemiological, clinical, and genetic characteristics of a pediatric population. Eur J Pediatr 171:1775\u20131785","journal-title":"Eur J Pediatr"},{"key":"3186_CR7","unstructured":"Majeed HA, Quabazard Z, Hijazi Z et\u00a0al (1990) The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis). A six-year study. Q\u00a0J Med 75:607\u2013616"},{"key":"3186_CR8","doi-asserted-by":"crossref","unstructured":"Kondi A, Hentgen V, Piram M et\u00a0al (2010) Validation of the new paediatric criteria for the diagnosis of familial Mediterranean fever: data from a mixed population of 100\u00a0children from the French reference centre for auto-inflammatory disorders. Rheumatology (Oxford) 49:2200\u20132203","DOI":"10.1093\/rheumatology\/keq252"},{"key":"3186_CR9","doi-asserted-by":"crossref","first-page":"e474","DOI":"10.1542\/peds.2006-1434","volume":"119","author":"Kallinich","year":"2007","unstructured":"Kallinich T, Haffner D, Niehues T et\u00a0al (2007) Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 119:e474\u2013e483","journal-title":"Pediatrics"},{"key":"3186_CR10","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2141.2009.07733.x","volume":"146","author":"Chae","year":"2009","unstructured":"Chae JJ, Aksentijevich I, Kastner DL (2009) Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy. Br J Haematol 146:467\u2013478","journal-title":"Br J Haematol"},{"key":"3186_CR11","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","volume":"157","author":"Hashkes","year":"2012","unstructured":"Hashkes PJ, Spalding SJ, Giannini EH et\u00a0al (2012) Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial. Ann Intern Med 157:533\u2013541","journal-title":"Ann Intern Med"},{"key":"3186_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/095952879708000106","volume":"80","author":"Still","year":"1897","unstructured":"Still GF (1897) On a form of chronic joint disease in children. Med Chir Trans 80:47\u201360 49","journal-title":"Med Chir Trans"},{"key":"3186_CR13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/ard.30.2.121","volume":"30","author":"Bywaters","year":"1971","unstructured":"Bywaters EG (1971) Still\u2019s disease in the adult. Ann Rheum Dis 30:121\u2013133","journal-title":"Ann Rheum Dis"},{"key":"3186_CR14","unstructured":"Yamaguchi M, Ohta A, Tsunematsu T et\u00a0al (1992) Preliminary criteria for classification of adult Still\u2019s disease. J\u00a0Rheumatol 19:424\u2013430"},{"key":"3186_CR15","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1080\/03009740510026616","volume":"35","author":"Evensen","year":"2006","unstructured":"Evensen KJ, Nossent HC (2006) Epidemiology and outcome of adult-onset Still\u2019s disease in Northern Norway. Scand J Rheumatol 35:48\u201351","journal-title":"Scand J Rheumatol"},{"key":"3186_CR16","doi-asserted-by":"crossref","unstructured":"Pascual V, Allantaz F, Arce E et\u00a0al (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J\u00a0Exp Med 201:1479\u20131486","DOI":"10.1084\/jem.20050473"},{"key":"3186_CR17","doi-asserted-by":"crossref","unstructured":"Maeno N, Takei S, Nomura Y et\u00a0al (2002) Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et\u00a0al. Arthritis Rheum 46:2539\u20132541 (Autorenantwort: 2541\u20132542)","DOI":"10.1002\/art.10389"},{"key":"3186_CR18","doi-asserted-by":"crossref","unstructured":"Omoyinmi E, Hamaoui R, Pesenacker A et\u00a0al (2012) Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis. Rheumatology (Oxford) 51:1881\u20131886","DOI":"10.1093\/rheumatology\/kes162"},{"key":"3186_CR19","doi-asserted-by":"crossref","first-page":"e20014","DOI":"10.1371\/journal.pone.0020014","volume":"6","author":"Lasiglie","year":"2011","unstructured":"Lasiglie D, Traggiai E, Federici S et\u00a0al (2011) Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients. PLoS One 6:e20014","journal-title":"PLoS One"},{"key":"3186_CR20","doi-asserted-by":"crossref","unstructured":"Ruperto N, Brumer HI, Quartier P et\u00a0al (2012) Two randomized trials of canakinumab in systemic juvenile idiopathic artritis. N\u00a0Engl J Med 367:2396\u20132406","DOI":"10.1056\/NEJMoa1205099"},{"key":"3186_CR21","doi-asserted-by":"crossref","unstructured":"Tausche AK, Manger B, Muller-Ladner U, Schmidt\u00a0B (2012) Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia. Z\u00a0Rheumatol 71:224\u2013230","DOI":"10.1007\/s00393-011-0953-9"},{"key":"3186_CR22","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","volume":"65","author":"Zhang","year":"2006","unstructured":"Zhang W, Doherty M, Bardin T et\u00a0al (2006) EULAR evidence based recommendations for gout. Part\u00a0II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65:1312\u20131324","journal-title":"Ann Rheum Dis"},{"key":"3186_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/BOR.0b013e32834ff637","volume":"24","author":"Jordan","year":"2012","unstructured":"Jordan KM (2012) Up-to-date management of gout. Curr Opin Rheumatol 24:145\u2013151","journal-title":"Curr Opin Rheumatol"},{"key":"3186_CR24","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","volume":"440","author":"Martinon","year":"2006","unstructured":"Martinon F, Petrilli V, Mayor A et\u00a0al (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237\u2013241","journal-title":"Nature"},{"key":"3186_CR25","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/ar2952","volume":"12","author":"Busso","year":"2010","unstructured":"Busso N, So A (2010) Mechanisms of inflammation in gout. Arthritis Res Ther 12:206","journal-title":"Arthritis Res Ther"},{"key":"3186_CR26","doi-asserted-by":"crossref","unstructured":"Di Giovine FS, Malawista SE, Nuki G, Duff GW (1987) Interleukin\u00a01 (IL\u00a01) as a mediator of crystal arthritis. Stimulation of T cell and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J\u00a0Immunol 138:3213\u20133218","DOI":"10.4049\/jimmunol.138.10.3213"},{"key":"3186_CR27","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1136\/ard.2010.128454","volume":"69","author":"Schlesinger","year":"2010","unstructured":"Schlesinger N, Thiele RG (2010) The pathogenesis of bone erosions in gouty arthritis. Ann Rheum Dis 69:1907\u20131912","journal-title":"Ann Rheum Dis"},{"key":"3186_CR28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11926-008-0036-3","volume":"10","author":"Nuki","year":"2008","unstructured":"Nuki G (2008) Colchicine: its mechanism of action and efficacy in crystal-induced inflammation. Curr Rheumatol Rep 10:218\u2013227","journal-title":"Curr Rheumatol Rep"},{"key":"3186_CR29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.27327","volume":"62","author":"Terkeltaub","year":"2010","unstructured":"Terkeltaub RA, Furst DE, Bennett K et\u00a0al (2010) High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 62:1060\u20131068","journal-title":"Arthritis Rheum"},{"key":"3186_CR30","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1002\/acr.21690","volume":"Res","author":"Schumacher","year":"2012","unstructured":"Schumacher HR Jr, Evans RR, Saag KG et\u00a0al (2012) Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase\u00a0III randomized, double-blind, placebo-controlled, confirmatory efficacy study. Arthritis Care Res (Hoboken) 64:1462\u20131470","journal-title":"Arthritis Care"},{"key":"3186_CR31","doi-asserted-by":"crossref","unstructured":"K\u00f6tter I, Schedel J, K\u00fcmmerle-Deschner JB (2009) Periodische Fiebersyndrome\/autoinflammatorische Syndrome. Z\u00a0Rheumatol 68:137\u2013149","DOI":"10.1007\/s00393-009-0449-z"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-012-3186-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-012-3186-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-012-3186-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T22:19:09Z","timestamp":1688077149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-012-3186-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,6]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["3186"],"URL":"https:\/\/doi.org\/10.1007\/s00108-012-3186-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,6]]}}}